- 专利标题： Compositions and methods for C. difficile treatment
-
申请号： US16313791申请日： 2017-07-03
-
公开(公告)号： US10849936B2公开(公告)日： 2020-12-01
- 发明人: Matthew J. Hamilton , Alexander Khoruts , Michael J. Sadowsky , Christopher M. Staley
- 申请人： REGENTS OF THE UNIVERSITY OF MINNESOTA
- 申请人地址： US MN Minneapolis
- 专利权人： Regents of the University of Minnesota
- 当前专利权人： Regents of the University of Minnesota
- 当前专利权人地址： US MN Minneapolis
- 代理机构： Arnold & Porter Kaye Scholer LLP
- 国际申请： PCT/US2017/040591 WO 20170703
- 国际公布： WO2018/006088 WO 20180104
- 主分类号： A61K35/74
- IPC分类号： A61K35/74 ; A61K9/00 ; A61P31/04 ; A61K9/19 ; A61K31/43 ; A61K9/16 ; A61K9/20 ; A01N1/02
摘要：
The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of a pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.
公开/授权文献
- US20190247445A1 COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT 公开/授权日：2019-08-15
信息查询
